37
Views
111
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1

, , , , , & show all
Pages 6488-6500 | Received 04 Mar 2004, Accepted 21 Apr 2004, Published online: 27 Mar 2023

REFERENCES

  • Alkema, M. J., Jacobs J., Voncken J. W., Jenkins N. A., Copeland N. G., Satijn D. P., Otte A. P., Berns A., and van Lohuizen M.. 1997. MPc2, a new murine homolog of the Drosophila polycomb protein is a member of the mouse polycomb transcriptional repressor complex. J. Mol. Biol. 273:993–1003.
  • Barton, G. M., and Medzhitov R.. 2003. Toll-like receptor signaling pathways. Science 300:1524–1525.
  • Batchvarova, N., Wang X. Z., and Ron D.. 1995. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 14:4654–4661.
  • Bendall, H. H., Scherer D. C., Edson C. R., Ballard D. W., and Oltz E. M.. 1997. Transcription factor NF-kappa B regulates inducible Oct-2 gene expression in precursor B lymphocytes J. Biol. Chem. 272:28826–28828.
  • Briskin, M., Kuwabara M. D., Sigman D. S., and Wall R.. 1988. Induction of kappa transcription by interferon-gamma without activation of NF-kappa B. Science 242:1036–1037.
  • Claudio, E., Brown K., Park S., Wang H., and Siebenlist U.. 2002. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958–965.
  • Coope, H. J., Atkinson P. G., Huhse B., Belich M., Janzen J., Holman M. J., Klaus G. G., Johnston L. H., and Ley S. C.. 2002. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 21:5375–5385.
  • Dadgostar, H., Zarnegar B., Hoffmann A., Qin X. F., Truong U., Rao G., Baltimore D., and Cheng G.. 2002. Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc. Natl. Acad. Sci. USA 99:1497–1502.
  • de Groot, R. P., Karperien M., Pals C., and Kruijer W.. 1991. Characterization of the mouse junD promoter—high basal level activity due to an octamer motif. EMBO J. 10:2523–2532.
  • Dejardin, E., Droin N. M., Delhase M., Haas E., Cao Y., Makris C., Li Z. W., Karin M., Ware C. F., and Green D. R.. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525–535.
  • De Smaele, E., Zazzeroni F., Papa S., Nguyen D. U., Jin R., Jones J., Cong R., and Franzoso G.. 2001. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414:308–313.
  • Formstecher, E., Ramos J. W., Fauquet M., Calderwood D. A., Hsieh J. C., Canton B., Nguyen X. T., Barnier J. V., Camonis J., Ginsberg M. H., and Chneiweiss H.. 2001. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1:239–250.
  • Frazier-Jessen, M. R., Thompson C. D., Brown R., Rawat R., Nordan R. P., and Feldman G. M.. 2002. NF-κB elements contribute to junB inducibility by lipopolysaccharide in the murine macrophage cell line RAW264. 7. FEBS Lett. 513:203–207.
  • Ghosh, S., and Karin M.. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109:S81–S96.
  • Grumont, R., Hochrein H., O'Keeffe M., Gugasyan R., White C., Caminschi I., Cook W., and Gerondakis S.. 2001. c-Rel regulates interleukin 12 p70 expression in CD8+ dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:1021–1032.
  • Grumont, R. J., Rasko J. E., Strasser A., and Gerondakis S.. 1996. Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene. Mol. Cell. Biol. 16:2913–2921.
  • Guha, M., and Mackman N.. 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 13:85–94.
  • Hatada, E. N., Krappmann D., and Scheidereit C.. 2000. NF-kappaB and the innate immune response. Curr. Opin. Immunol. 12:52–58.
  • Hinz, M., Lemke P., Anagnostopoulos I., Hacker C., Krappmann D., Mathas S., Dörken B., Zenke M., Stein H., and Scheidereit C.. 2002. Nuclear factor κB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J. Exp. Med. 196:605–617.
  • Huang, S., Shu L., Dilling M. B., Easton J., Harwood F. C., Ichijo H., and Houghton P. J.. 2003. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol. Cell 11:1491–1501.
  • Huo, L., and Rothstein T. L.. 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154:3300–3309.
  • Karin, M., and Ben-Neriah Y.. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621–663.
  • Kayagaki, N., Yan M., Seshasayee D., Wang H., Lee W., French D. M., Grewal I. S., Cochran A. G., Gordon N. C., Yin J., Starovasnik M. A., and Dixit V. M.. 2002. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity 17:515–524.
  • Krappmann, D., Patke A., Heissmeyer V., and Scheidereit C.. 2001. B-cell receptor- and phorbol ester-induced NF-κB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's. Mol. Cell. Biol. 21:6640–6650.
  • Kyriakis, J. M., and Avruch J.. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807–869.
  • Levi, B. Z., Hashmueli S., Gleit-Kielmanowicz M., Azriel A., and Meraro D.. 2002. ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J. Interferon Cytokine Res. 22:153–160.
  • Li, J., Peet G. W., Balzarano D., Li X., Massa P., Barton R. W., and Marcu K. B.. 2001. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276:18579–18590.
  • Li, Q., and Verma I. M.. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725–734.
  • Li, X., Massa P. E., Hanidu A., Peet G. W., Aro P., Savitt A., Mische S., Li J., and Marcu K. B.. 2002. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. J. Biol. Chem. 277:45129–45140.
  • Lu, R., Medina K. L., Lancki D. W., and Singh H.. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17:1703–1708.
  • Malcolm, K. C., Arndt P. G., Manos E. J., Jones D. A., and Worthen G. S.. 2003. Microarray analysis of lipopolysaccharide-treated human neutrophils. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L663–L670.
  • Masuda, K., Shima H., Watanabe M., and Kikuchi K.. 2001. MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein. J. Biol. Chem. 276:39002–39011.
  • Mathas, S., Hinz M., Anagnostopoulos I., Krappmann D., Lietz A., Jundt F., Bommert K., Mechta-Grigoriou F., Stein H., Dorken B., and Scheidereit C.. 2002. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J. 21:4104–4113.
  • Matsuguchi, T., Musikacharoen T., Johnson T. R., Kraft A. S., and Yoshikai Y.. 2001. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol. Cell. Biol. 21:6999–7009.
  • Messmer, D., Messmer B., and Chiorazzi N.. 2003. The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. Int. Immunol. 15:491–503.
  • Mordmuller, B., Krappmann D., Esen M., Wegener E., and Scheidereit C.. 2003. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep. 4:82–87.
  • Nozaki, S., Sledge G. W., Jr., and Nakshatri H.. 2001. Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene 20:2178–2185.
  • O'Brien, D. P., Oltz E. M., and Van Ness B. G.. 1997. Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-κB-dependent and -independent pathways of activation. Mol. Cell. Biol. 17:3477–3487.
  • Olive, M., Krylov D., Echlin D. R., Gardner K., Taparowsky E., and Vinson C.. 1997. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J. Biol. Chem. 272:18586–18594.
  • Pahl, H. L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866.
  • Saccani, S., Pantano S., and Natoli G.. 2002. p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol. 3:69–75.
  • St. Pierre, B., Flock G., Zacksenhaus E., and Egan S. E.. 2002. Stra13 homodimers repress transcription through class B E-box elements. J. Biol. Chem. 277:46544–46551.
  • Sun, Z., Arendt C. W., Ellmeier W., Schaeffer E. M., Sunshine M. J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P. L., and Littman D. R.. 2000. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404:402–407.
  • Svaren, J., Sevetson B. R., Apel E. D., Zimonjic D. B., Popescu N. C., and Milbrandt J.. 1996. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16:3545–3553.
  • Tanguay, D. A., Dickinson J. A., McManus B. J., Huo L., Rothstein T. L., and Chiles T. C.. 1994. Activation of AP-1 in primary B lymphocytes by surface immunoglobulin requires de novo Jun-B synthesis. Cell Immunol. 158:281–291.
  • Ubeda, M., Vallejo M., and Habener J. F.. 1999. CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins. Mol. Cell. Biol. 19:7589–7599.
  • Vietor, I., Vadivelu S. K., Wick N., Hoffman R., Cotten M., Seiser C., Fialka I., Wunderlich W., Haase A., Korinkova G., Brosch G., and Huber L. A.. 2002. TIS7 interacts with the mammalian SIN3 histone deacetylase complex in epithelial cells. EMBO J. 21:4621–4631.
  • Ward, Y., Gupta S., Jensen P., Wartmann M., Davis R. J., and Kelly K.. 1994. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 367:651–654.
  • Weeks, R. S., and Sibley C. H.. 1987. Molecular analysis of immunoglobulin expression in variants of murine B lymphoma, 70Z/3 Somat. Cell Mol. Genet. 13:205–219.
  • Yilmaz, Z. B., Weih D. S., Sivakumar V., and Weih F.. 2003. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22:121–130.
  • Zhao, B., Bowden R. A., Stavchansky S. A., and Bowman P. D.. 2001. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am. J. Physiol. Cell Physiol. 281:C1587–C1595.
  • Zhao, B., Stavchansky S. A., Bowden R. A., and Bowman P. D.. 2003. Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. Am. J. Physiol. Cell Physiol. 284:C1577–C1583.
  • Zhou, A., Scoggin S., Gaynor R. B., and Williams N. S.. 2003. Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference. Oncogene 22:2054–2064.
  • Zhu, N., Ramirez L. M., Lee R. L., Magnuson N. S., Bishop G. A., and Gold M. R.. 2002. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappaB pathway. J. Immunol. 168:744–754.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.